Northwest Bancshares’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.33M Sell
9,531
-61
-0.6% -$14.2K 0.46% 55
2025
Q4
$1.99M Sell
9,592
-1,298
-12% -$257K 0.38% 59
2025
Q3
$2.02M Sell
10,890
-311
-3% -$53.3K 0.34% 59
2025
Q2
$1.71M Sell
11,201
-329
-3% -$50.6K 0.3% 64
2025
Q1
$1.91M Buy
11,530
+96
+0.8% +$15K 0.35% 59
2024
Q4
$1.65M Sell
11,434
-164
-1% -$25.4K 0.31% 60
2024
Q3
$1.88M Sell
11,598
-429
-4% -$68.4K 0.32% 60
2024
Q2
$1.76M Sell
12,027
-150
-1% -$22.3K 0.3% 58
2024
Q1
$1.93M Buy
12,177
+31
+0.3% +$4.93K 0.3% 60
2023
Q4
$1.9M Sell
12,146
-666
-5% -$102K 0.35% 56
2023
Q3
$2M Buy
12,812
+867
+7% +$143K 0.38% 57
2023
Q2
$1.98M Buy
11,945
+11
+0.1% +$1.77K 0.36% 60
2023
Q1
$1.85M Sell
11,934
-19
-0.2% -$3.07K 0.36% 66
2022
Q4
$2.11M Sell
11,953
-739
-6% -$128K 0.42% 57
2022
Q3
$2.07M Sell
12,692
-120
-0.9% -$20.3K 0.48% 53
2022
Q2
$2.27M Sell
12,812
-507
-4% -$90.3K 0.51% 52
2022
Q1
$2.36M Sell
13,319
-37
-0.3% -$6.3K 0.45% 61
2021
Q4
$2.28M Buy
13,356
+300
+2% +$49.1K 0.45% 61
2021
Q3
$2.11M Buy
13,056
+50
+0.4% +$8.53K 0.48% 60
2021
Q2
$2.14M Sell
13,006
-25
-0.2% -$4.14K 0.49% 59
2021
Q1
$2.14M Buy
13,031
+476
+4% +$77K 0.51% 60
2020
Q4
$1.98M Buy
12,555
+268
+2% +$39.5K 0.51% 63
2020
Q3
$1.83M Sell
12,287
-455
-4% -$67.3K 0.47% 70
2020
Q2
$1.79M Buy
12,742
+154
+1% +$22.4K 0.49% 69
2020
Q1
$1.65M Sell
12,588
-250
-2% -$35.5K 0.82% 47
2019
Q4
$1.87M Sell
12,838
-519
-4% -$70.4K 0.72% 51
2019
Q3
$1.73M Sell
13,357
-400
-3% -$52.7K 0.71% 51
2019
Q2
$1.92M Sell
13,757
-104
-0.8% -$14.4K 0.81% 50
2019
Q1
$1.94M Sell
13,861
-46
-0.3% -$6.16K 0.84% 48
2018
Q4
$1.79M Sell
13,907
-290
-2% -$40.5K 0.87% 48
2018
Q3
$1.96M Sell
14,197
-834
-6% -$111K 0.87% 31
2018
Q2
$1.82M Sell
15,031
-1,894
-11% -$236K 0.77% 29
2018
Q1
$2.17M Sell
16,925
-268
-2% -$36.2K 0.89% 20
2017
Q4
$2.4M Buy
+17,193
New +$2.39M 0.98% 14

Other funds holding JNJ

Northwest Bancshares's JNJ Position: Q1 2026 in Review

Northwest Bancshares reduced its Johnson & Johnson (JNJ) stake by 0.64% in Q1 2026, selling an estimated $14.2K and leaving 9,531 shares worth $2.33M. The position accounts for 0.46% of the portfolio, ranked #55.

Northwest Bancshares first reported a position in JNJ in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.4M in Q4 2017. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Northwest Bancshares held 9,531 shares of Johnson & Johnson worth $2.33M as of Q1 2026.
  • Northwest Bancshares sold 61 Johnson & Johnson shares in Q1 2026, an estimated $14.2K.
  • Johnson & Johnson made up 0.46% of Northwest Bancshares's portfolio in Q1 2026, its #55 holding.
  • Northwest Bancshares first reported a position in Johnson & Johnson in Q4 2017 and has held it in 34 quarters since.
  • Northwest Bancshares's Johnson & Johnson position peaked at $2.4M in Q4 2017.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Northwest Bancshares's 13F filing for Q1 2026, filed 12 May 2026.